Intellectual property rights: An overview and implications in pharmaceutical industry

被引:30
|
作者
Saha, Chandra Nath [1 ]
Bhattacharya, Sanjib [2 ]
机构
[1] Claris Lifesci Ltd, Qual Assurance Dept, Ahmadabad, Gujarat, India
[2] Bengal Sch Technol Coll Pharm, Pharmacognosy Div, Delhi Rd, Sugandha 712102, W Bengal, India
关键词
Drug; intellectual property; license; patent; pharmaceutical;
D O I
10.4103/2231-4040.82952
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intellectual property rights (IPR) have been defined as ideas, inventions, and creative expressions based on which there is a public willingness to bestow the status of property. IPR provide certain exclusive rights to the inventors or creators of that property, in order to enable them to reap commercial benefits from their creative efforts or reputation. There are several types of intellectual property protection like patent, copyright, trademark, etc. Patent is a recognition for an invention, which satisfies the criteria of global novelty, non-obviousness, and industrial application. IPR is prerequisite for better identification, planning, commercialization, rendering, and thereby protection of invention or creativity. Each industry should evolve its own IPR policies, management style, strategies, and so on depending on its area of specialty. Pharmaceutical industry currently has an evolving IPR strategy requiring a better focus and approach in the coming era.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 50 条